Group 1: Stock Performance - Cardinal Health's stock closed at $148.96, reflecting a -3.64% change from the previous day's closing price, underperforming the S&P 500's daily loss of 0.5% [1] - Over the past month, Cardinal Health's shares have appreciated by 3.58%, outperforming the Medical sector's loss of 0.7% and the S&P 500's gain of 2.74% [1] Group 2: Upcoming Earnings Disclosure - Cardinal Health is set to release its earnings report on October 30, 2025, with an expected EPS of $2.22, representing an 18.09% increase from the prior-year quarter [2] - The Zacks Consensus Estimate projects net sales of $59.05 billion, up 12.96% from the year-ago period [2] Group 3: Annual Estimates - For the annual period, the Zacks Consensus Estimates anticipate earnings of $9.41 per share and revenue of $249.31 billion, indicating increases of +14.2% and +12.01%, respectively, from the last year [3] - Recent changes to analyst estimates reflect shifting dynamics in short-term business patterns, with positive revisions indicating analysts' confidence in business performance and profit potential [3] Group 4: Valuation Metrics - Cardinal Health is currently trading at a Forward P/E ratio of 16.42, which is higher than the industry average Forward P/E of 14.68, suggesting a premium valuation [6] - The company has a PEG ratio of 1.31, compared to the Medical - Dental Supplies industry average PEG ratio of 1.65 [7] Group 5: Industry Ranking - The Medical - Dental Supplies industry has a Zacks Industry Rank of 169, placing it in the bottom 32% of all 250+ industries [7] - The Zacks Industry Rank measures the strength of industry groups by evaluating the average Zacks Rank of individual stocks within those groups [8]

Company Performance - Nice (NICE) closed at $147.14, reflecting a -3.33% change from the previous day, underperforming the S&P 500's loss of 0.5% [1] - Over the past month, shares of Nice have increased by 8.47%, surpassing the Computer and Technology sector's gain of 8.21% and the S&P 500's gain of 2.74% [1] Earnings Forecast - The upcoming earnings release for Nice is anticipated to show an EPS of $3.17, representing a 10.07% growth year-over-year [2] - Revenue is projected at $727.92 million, indicating a 5.5% increase compared to the same quarter last year [2] Annual Estimates - For the full year, Zacks Consensus Estimates predict earnings of $12.44 per share and revenue of $2.93 billion, reflecting growth of +11.87% and +7% respectively from the previous year [3] - Recent adjustments to analyst estimates for Nice are important as they indicate evolving short-term business trends and analysts' confidence in performance [3] Valuation Metrics - Nice has a Forward P/E ratio of 12.24, which is a discount compared to the industry average Forward P/E of 31.31 [6] - The company has a PEG ratio of 1.08, significantly lower than the industry average PEG ratio of 2.28 [6] Industry Context - Nice operates within the Internet - Software industry, which is part of the Computer and Technology sector, holding a Zacks Industry Rank of 73, placing it in the top 30% of over 250 industries [7] - The Zacks Industry Rank indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

ZIM Integrated Shipping Services (ZIM) ended the recent trading session at $14.08, demonstrating a -3.1% change from the preceding day's closing price. This change lagged the S&P 500's daily loss of 0.5%. Elsewhere, the Dow lost 0.38%, while the tech-heavy Nasdaq lost 0.5%. The container shipping company's shares have seen an increase of 2.25% over the last month, surpassing the Transportation sector's loss of 2.03% and falling behind the S&P 500's gain of 2.74%.Market participants will be closely following ...

Group 1 - Nu Holdings Ltd. (NU) stock decreased by 1.44% to $15.78, underperforming the S&P 500's daily loss of 0.5% [1] - Over the past month, shares of Nu Holdings have appreciated by 9.36%, outperforming the Finance sector's gain of 1.4% and the S&P 500's gain of 2.74% [1] Group 2 - Nu Holdings is expected to report an EPS of $0.15, reflecting a 25% increase from the same quarter last year, with a revenue forecast of $3.87 billion, up 31.66% year-over-year [2] - For the entire fiscal year, earnings are projected at $0.56 per share and revenue at $14.95 billion, representing increases of 24.44% and 29.77% respectively from the previous year [3] Group 3 - Recent adjustments to analyst estimates for Nu Holdings indicate positive sentiment regarding the company's business operations and profit generation capabilities [4] - The Zacks Rank system, which evaluates estimate changes, has shown that upward revisions correlate with stock price performance [5] Group 4 - Nu Holdings has a Forward P/E ratio of 28.76, significantly higher than the industry average of 10.54, indicating it is trading at a premium [7] - The company holds a PEG ratio of 0.83, compared to the Banks - Foreign industry average PEG ratio of 1.02 [7] Group 5 - The Banks - Foreign industry, which includes Nu Holdings, has a Zacks Industry Rank of 88, placing it in the top 36% of over 250 industries [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]

Company Performance - Apple (AAPL) closed at $256.87, reflecting a +1.81% change from the previous day's closing price, outperforming the S&P 500's daily loss of 0.5% [1] - Prior to the recent trading session, Apple shares had gained 9.47%, surpassing the Computer and Technology sector's gain of 8.21% and the S&P 500's gain of 2.74% [1] Earnings Expectations - The upcoming earnings release is expected to show an EPS of $1.74, a 6.1% increase compared to the same quarter last year, with projected revenue of $101.13 billion, reflecting a 6.53% rise from the equivalent quarter last year [2] - For the entire fiscal year, earnings are projected at $7.36 per share and revenue at $412.1 billion, indicating changes of +9.04% and +5.39% respectively from the prior year [3] Analyst Forecasts - Recent revisions to analyst forecasts for Apple are important as they reflect short-term business trends, with positive changes indicating a favorable outlook on business health and profitability [4] - The Zacks Rank system, which incorporates estimate changes, provides actionable ratings, with Apple currently holding a Zacks Rank of 3 (Hold) [5][6] Valuation Metrics - Apple is currently traded at a Forward P/E ratio of 34.29, which is a premium compared to the industry average Forward P/E of 13.27 [7] - The company has a PEG ratio of 2.62, compared to the Computer - Micro Computers industry's average PEG ratio of 1.52 [7] Industry Context - The Computer - Micro Computers industry is part of the Computer and Technology sector, holding a Zacks Industry Rank of 22, placing it in the top 9% of over 250 industries [8]

Company Performance - MPLX LP closed at $51.12, with a daily increase of +1.97%, outperforming the S&P 500's loss of 0.29% [1] - Over the past month, MPLX shares have decreased by 1.26%, underperforming the Oils-Energy sector's gain of 2.23% and the S&P 500's gain of 3.08% [1] Upcoming Earnings - MPLX is set to release its earnings report on November 4, 2025, with an expected EPS of $1.12, indicating a growth of 10.89% year-over-year [2] - The consensus estimate for revenue is projected at $3.26 billion, reflecting a 9.53% increase compared to the same quarter last year [2] Full-Year Estimates - The Zacks Consensus Estimates for MPLX's full-year earnings are $4.38 per share and revenue of $12.7 billion, representing year-over-year changes of +4.04% and +6.4%, respectively [3] Analyst Sentiment - Recent changes in analyst estimates for MPLX LP are important, as positive revisions indicate optimism regarding the company's business and profitability [3][4] Zacks Rank - MPLX currently holds a Zacks Rank of 3 (Hold), with the consensus EPS projection having moved 1.14% lower in the past 30 days [5] Valuation Metrics - MPLX is trading at a Forward P/E ratio of 11.45, which is below the industry average of 16.69 [6] - The company has a PEG ratio of 1.36, compared to the industry average PEG ratio of 2.18 [6] Industry Context - The Oil and Gas - Production and Pipelines industry, part of the Oils-Energy sector, has a Zacks Industry Rank of 58, placing it in the top 24% of over 250 industries [7]

Company Performance - VirTra, Inc. (VTSI) stock decreased by 1.79% to $5.49, underperforming the S&P 500 which fell by 0.29% [1] - Over the past month, the stock has declined by 3.79%, while the Aerospace sector gained 5% and the S&P 500 increased by 3.08% [1] Earnings Expectations - Analysts expect VirTra, Inc. to report earnings of $0.05 per share, indicating no growth compared to the prior-year quarter [2] - Revenue is anticipated to be $7.48 million, showing stability relative to the same quarter last year [2] Full Year Projections - For the full year, earnings are projected at $0.33 per share, reflecting a growth of 175% from the previous year [3] - Revenue is estimated at $29.79 million, representing a 10.12% increase from the prior year [3] Analyst Estimate Revisions - Recent changes in analyst estimates suggest a positive outlook for VirTra, Inc., as these revisions often align with short-term business trends [3][4] - The Zacks Rank system, which incorporates these estimate changes, provides actionable insights for investors [4] Valuation Metrics - VirTra, Inc. has a Forward P/E ratio of 16.94, which is in line with the industry average [6] - The Electronics - Military industry, part of the Aerospace sector, holds a Zacks Industry Rank of 106, placing it in the top 43% of over 250 industries [6] Zacks Industry Rank Insights - The Zacks Industry Rank evaluates the strength of industry groups based on the average Zacks Rank of individual stocks [7] - Historically, the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Company Performance - GE Aerospace closed at $300.30, reflecting a -1.74% change from the previous day, underperforming the S&P 500's 0.29% loss [1] - Over the past month, GE Aerospace shares have increased by 11.57%, outperforming the Aerospace sector's 5% gain and the S&P 500's 3.08% increase [1] Upcoming Financial Results - GE Aerospace is set to announce its earnings on October 21, 2025, with an expected EPS of $1.45, representing a 26.09% increase year-over-year [2] - Revenue is forecasted to be $10.28 billion, indicating a 14.92% growth compared to the same quarter of the previous year [2] Fiscal Year Estimates - For the entire fiscal year, earnings are projected at $5.87 per share, a 27.61% increase from the previous year, while revenue is expected to be $40.38 billion, reflecting a -4.42% change [3] - Recent analyst estimate revisions suggest a positive outlook for GE Aerospace's business performance and profit potential [3] Valuation Metrics - GE Aerospace has a Forward P/E ratio of 52.07, significantly higher than the industry average of 24.91, indicating a premium valuation [6] - The company has a PEG ratio of 3.29, compared to the Aerospace - Defense industry's average PEG ratio of 2.17 [7] Industry Ranking - The Aerospace - Defense industry holds a Zacks Industry Rank of 106, placing it in the top 43% of over 250 industries [7] - The Zacks Rank system indicates that GE Aerospace currently holds a Zacks Rank of 2 (Buy), reflecting a favorable outlook based on recent estimate changes [5]

Group 1: Stock Performance - Qualcomm (QCOM) closed at $173.55, marking a +2.37% move from the prior day, outperforming the S&P 500, which registered a loss of 0.29% [1] - Prior to the latest trading session, Qualcomm shares had gained 6.51%, lagging behind the Computer and Technology sector's gain of 8.98% and outpacing the S&P 500's gain of 3.08% [1] Group 2: Upcoming Financial Results - Qualcomm's upcoming EPS is projected at $2.86, indicating a 6.32% increase compared to the same quarter of the previous year [2] - The consensus estimate for quarterly revenue is $10.77 billion, up 5.16% from the year-ago period [2] Group 3: Full-Year Estimates - Full-year Zacks Consensus Estimates for Qualcomm are calling for earnings of $11.89 per share and revenue of $43.8 billion, representing year-over-year changes of +16.34% and +12.41%, respectively [3] - Recent changes to analyst estimates for Qualcomm indicate analysts' confidence in the business performance and profit potential [3] Group 4: Valuation Metrics - Qualcomm is currently traded at a Forward P/E ratio of 14.26, which is significantly lower than the industry average Forward P/E of 36.44, suggesting Qualcomm is trading at a discount [6] - Qualcomm holds a PEG ratio of 2.01, which is comparable to the industry average PEG ratio of 2.04 [7] Group 5: Industry Context - The Electronics - Semiconductors industry, part of the Computer and Technology sector, has a Zacks Industry Rank of 190, placing it in the bottom 24% of all 250+ industries [8] - The Zacks Industry Rank assesses the strength of industry groups, with top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [8]

Company Performance - AbbVie closed at $219.99, reflecting a -1.18% change from the previous day, underperforming the S&P 500's loss of 0.29% [1] - Over the past month, AbbVie shares gained 6.84%, outperforming the Medical sector's loss of 0.33% and the S&P 500's gain of 3.08% [1] Upcoming Earnings - AbbVie's upcoming earnings per share (EPS) are projected to be $3.26, indicating an 8.67% increase from the same quarter last year [2] - Revenue is estimated at $15.54 billion, reflecting a 7.5% rise from the equivalent quarter last year [2] Full Year Projections - For the full year, earnings are projected at $12.02 per share and revenue at $60.64 billion, representing changes of +18.77% and +7.64% from the prior year [3] - Recent adjustments to analyst estimates indicate evolving short-term business trends, with positive revisions suggesting analyst optimism [3] Zacks Rank and Valuation - AbbVie currently holds a Zacks Rank of 3 (Hold), with a Forward P/E ratio of 18.53, which is a premium compared to the industry average of 14.34 [5] - The PEG ratio for AbbVie is 1.33, compared to the Large Cap Pharmaceuticals industry average of 1.53 [6] Industry Overview - The Large Cap Pharmaceuticals industry is part of the Medical sector and holds a Zacks Industry Rank of 106, placing it in the top 43% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]